Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Signaling Pathways Explain Kidney Growth
Scientific Advances

Signaling Pathways Explain Kidney Growth

By Office of CommunicationsJun 4, 2015
Share
Facebook Twitter Email
Dean Eric Neilson
Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean, coauthored a new paper revealing the complex biochemical mechanisms underlying renal hypertrophy.

Kidney mass increases or adapts to growing body mass by the time we achieve early adulthood. When the body loses one kidney—from trauma, injury or donating a kidney—the remaining kidney also enlarges to maintain the requirements for glomerular filtration. These changes in kidney size are the result of renal hypertrophy.

Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean, coauthored a new paper, published recently in the Journal of Clinical Investigation, which reveals the biochemical mechanisms underlying kidney hypertrophy.

Hypertrophy happens when the cells in an organ individually increase their size. The new study demonstrates that pathways involving the mTOR complex activate both modes of kidney enlargement. However, unique molecular signaling of that pathway depends on context.

Through a series of complex experiments, the authors showed during normal maturation that receptor tyrosine kinases on proximal tubular cells activate class I PI3K/PTEN to regulate an MTORC1/lysosomal effect on protein synthesis leading to adaptive hypertrophy.

Alternatively, after the loss of a kidney, blood flow to the remaining kidney increases, delivering more amino acids to the organ than before. This amino acid load activates class III PI3K enzymes and vesicular trafficking to lysosomes that also activates MTORC1. The class III PI3K pathway likely explains why kidneys grow bigger when people consume high-protein diets or develop diabetes.

“We now have good answers for century-old questions,” said Dr. Neilson, who started the research when he was chairman of Medicine at Vanderbilt University School of Medicine. “The answers are important because the precise biochemical signaling for renal hypertrophy has been uncertain and because that signaling can trigger or accelerate chronic kidney diseases. Knowing the different molecular pathways for hypertrophy also potentially offers new drugable targets that may be helpful someday for patients who are at risk for unwanted hypertrophy.”

Dr. Neilson collaborated with scientists from Vanderbilt, the Medical College of Georgia at Georgia Regents University and Texas A&M University on this work.

“The same common mechanism—activation of the mTOR complex—leads to hypertrophy, but how you get there is different for normal adaptation of kidney size or for the remarkable compensatory growth after loss of one kidney,” said coauthor Raymond Harris, MD, chief of Nephrology and Hypertension at Vanderbilt.

The work was supported by National Institutes of Health (NIH) grants DK83575, DK38226, DK51265 and DK46282; American Heart Association Scientist Development Grant 0630274N; start-up funds from Georgia Regents University Augusta; a VA Merit Award; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Uehara Memorial Foundation; and Grant-in-Aid for Research Activity Start-up from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Biochemistry Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.